Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Musgrave, D. S.
  • Bosch, P.
  • Ghivizzani, S.
  • Robbins, Paul D.
  • Evans, C. H.
  • Huard, J.

publication date

  • 1999

journal

  • Bone  Journal

abstract

  • The need to improve bone healing permeates the discipline of orthopedic surgery. Bone morphogenetic proteins (BMPs) are capable of inducing ectopic and orthotopic bone formation. However, the ideal approach with which to deliver BMPs remains unknown. Gene therapy to deliver BMPs offers several theoretical advantages over implantation of a recombinant BMP protein, including persistent BMP delivery and eliminating the need for a foreign body carrier. A replication defective adenoviral vector was constructed to carry the rhBMP-2 gene (AdBMP-2). The direct in vivo gene therapy approach was applied in both immunodeficient and immunocompetent animals to produce intramuscular bone as early as 2 weeks following injection. Radiographic and histologic analysis revealed radiodense bone containing mature bone marrow elements. Adenovirus-mediated delivery of a marker gene (beta-galactosidase) into control animals produced no bone but indicated the cells transduced with the AdBMP-2 vector. Furthermore, comparisons between immunodeficient and immunocompetent animals illustrated the magnitude and significance of the immune response. Gene therapy to deliver BMP-2 has innumerable potential clinical applications from bone defect healing to joint replacement prosthesis stabilization. This study is the first to establish the feasibility of in vivo gene therapy to deliver active BMP-2 and produce bone.

subject areas

  • Adenoviridae
  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Bone and Bones
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • Immunocompetence
  • Injections, Intramuscular
  • Lac Operon
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • Osteogenesis
  • Recombinant Proteins
  • Time Factors
  • Transforming Growth Factor beta
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 8756-3282

Digital Object Identifier (DOI)

  • 10.1016/s8756-3282(99)00086-1

PubMed ID

  • 10375195
scroll to property group menus

Additional Document Info

start page

  • 541

end page

  • 547

volume

  • 24

issue

  • 6

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support